“…Surfaceenhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) combined with ProteinChip technology is a high-throughput proteomic analysis approach which has been shown to be effective in the detection of biomarkers for early stage malignancy (Petricoin and Liotta, 2004). Using this combined technology, some new serum biomarkers with higher sensitivity were found for the early detection of different cancers, including prostate cancer (Okamoto et al, 2009;Yamamoto-Ishikawa et al, 2009), ovarian cancer (Høgdall et al, 2010;Tang et al, 2010), brain cancer , colorectal cancer (Yu et al, 2004;Helgason et al, 2010), breast cancer (Hu et al, 2005;Opstal-van Winden et al, 2011), lung cancer (Rathinam et al, 2011), and pancreatic cancer (Felix et al, 2011). However, reports on the protein profiling of different stages of ESCC development have not yet been published.…”